Because of its anti-inflammatory properties, CBD may even help treat acne.
Interest continues to grow. Last year, the federal government pledged $3 billion to research CBD.
“I do believe that cannabidiol has potential, absolutely,” Dr. Yasmin Hurd, a neuroscientist at Mount Sinai Hospital in New York City, told TODAY. Hurd’s research suggests CBD can may have positive effects on opioid addicts.
What does it do?
Most of the products claim to ease pain and anxiety. But whether or not these products actually contain the amount of CBD they advertise is up for debate, since they’re not approved by the FDA.
Currently the Food and Drug Administration has only approved one CBD product, a prescription drug called Epidiolex to treat two rare forms of epilepsy. In July, the FDA expanded what the drug is approved to treat, saying it can also be used for seizures associated with tuberous sclerosis complex.
CBD is everywhere lately — in skin care, coffee and even pet treats. But is it really all it’s hyped up to be?
In addition to treating epilepsy, research has shown CBD may help reduce anxiety for people who have schizophrenia or psychosis, or who are addicted to opiates.
The advent of potent cannabis oil concentrates, non-intoxicating CBD -rich products, and innovative, smokeless delivery systems has transformed the therapeutic landscape and changed the public conversation about cannabis.
What happens if the endocannabinoid system doesn’t function properly? What are the consequences of a chronically deficient or overactive endocannabinoid system?
In a word, disease.
In response to the FDA ’s historic decision, the Drug Enforcement Administration ( DEA ) announced in September 2018 that it had removed Epidiolex from Schedule I classification, a category reserved for dangerous drugs with no medical value. Henceforth, Epidiolex would be considered a Schedule V drug, the least dangerous designation under the Controlled Substances Act. The DEA later “descheduled” Epidiolex and removed it from the federal government’s list of controlled substances.
CBD has proven neuroprotective effects and its anti-cancer properties are being investigated at several academic research centers in the United States and elsewhere. A 2010 brain cancer study by California scientists found that CBD “enhances the inhibitory effects of THC on human glioblastoma cell proliferation and survival.” This means that CBD makes THC even more potent as an anticancer substance. Also in 2010, German researchers reported that CBD stimulates neurogenesis, the growth of new brain cells, in adult mammals.
CBD can actually lessen or neutralize the psychoactive effects of THC , depending on how much of each compound is consumed. Many people want the health benefits of cannabis without the high – or with less of a high. The fact that CBD is therapeutically potent as well as non-intoxicating, and easy to take as a CBD oil, makes it an appealing treatment option for those who are cautious about trying cannabis for the first time.
By modulating the endocannabinoid system and enhancing endocannabinoid tone, CBD and THC can slow – or in some cases stop – disease progression.